New app aims to safely automate insulin dosing for type 1 diabetes
NCT ID NCT07599982
First seen May 21, 2026 · Last updated May 21, 2026
Summary
This study tests whether a computer program called MODI can safely help adults with type 1 diabetes adjust their insulin doses. About 36 people who use daily insulin injections and a continuous glucose monitor will try the algorithm for 13 weeks. The main goal is to see if the program keeps blood sugar from dropping too low.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES (T1D) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Diabetes & Endocrine Treatment Specialisits (DETS)
Sandy City, Utah, 84093, United States
-
SUNY Upstate Medical Center
Albany, New York, 12246, United States
-
Texas Diabetes & Endocrinology
Austin, Texas, 78731, United States
Conditions
Explore the condition pages connected to this study.